Study of the R21/Matrix-M malaria vaccine
Part of Infections clinical trials.
This study looks at how well the R21/Matrix-M malaria vaccine works and how safe it is in children who received it. It compares children who got malaria (or died) to healthy children who also got the vaccine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is eligible to receive the R21/Matrix-M malaria vaccine based on their age.
- You live in an area where the R21/Matrix-M vaccine is being given.
- You are willing to let the study team see your child's vaccination and medical records.
- Your child has not received any doses of the RTS,S/AS01 malaria vaccine before.
- For children with malaria: your child has severe malaria, clinical malaria, or has died from any cause.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of experimental malaria vaccines to see if they are safe and help protect against malaria. It includes both adults and young children in malaria-affected areas.
This Phase 1/2 study tests a new vaccine meant to protect young children against malaria. If you qualify, your baby would get the study vaccine and be followed for about 12 months to check safety and early signs of protection.
This study tests a new long-acting malaria prevention injection (MMV371) in healthy adults and adolescents in Rwanda. Researchers will monitor how safe it is and how your body processes it over 24 weeks.
This study looks at how well the R21/Matrix-M malaria vaccine works in real-life settings for children under 5. If your child is eligible for the vaccine and has a fever, they may be able to join and help us understand the vaccine's impact.
This trial tests a seasonal vaccination schedule with the R21 malaria vaccine to help eliminate malaria in your community. It may be a good fit if you are looking for a way to protect yourself or your child from malaria during peak transmission seasons.
This trial tests if adding a malaria vaccine to seasonal preventive medicines helps protect young children better from malaria. It is for healthy children living in certain areas of Burkina Faso and Mali.
Hear when a new Malaria Falciparum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.